EpiVax was in Japan from May 8th – 15th hosting our semiannual immunogenicity seminar. The ‘Westin Immunogenicity Seminar’ was a great success. Thank you to all the wonderful speakers and attendees that made our seminar possible. We are looking forward to our following visit in the Fall, probably in late October, for our next meeting. We will keep you all up-to-date on our progress.
If you were unable to make it this year, please see the links below to our hand-out, containing the presenter’s slides. We hope you will make it to your next meeting in the Fall.
Links
Printed Program (two files)
Slides not included in the program:
- Dr. Naonobu Sugiyama, MD, PhD “Immunogenicity and Clinical Outcomes in RA Treatment”
- Dr. Chris Bailey-Kellogg PhD “New Technologies: Immunogenicity, Deimmunization & 3D Modeling”
URI/EpiVax Immunogenicity Seminar 2013
Sponsored by: The Institute for Immunology and Informatics (iCubed), University of Rhode Island & EpiVax, Inc.
Venue: The Westin Tokyo – Kiri Room
Thursday, May 9th, 9:30 am – 5:00 pm
1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan
Dr. Keizo Yoshida, PhD.
EpiVax Asia
Dr. Annie De Groot M.D.
Professor and Director, Institute of Immunology and Informatics,
University of Rhode Island, CEO/CSO, EpiVax
Dr. Naonobu Sugiyama, MD, PhD
JCR-board certified rheumatologist
Associate Director, RA & Inflammation
Medical Affairs Pfizer Japan
Ms. Frances Terry
Bioinformatics Program Manager, EpiVax, Inc.
Dr. Shingo Niimi PhD
Section Director
Division of Biological Chemistry and Biologics
NIH Japan
Dr. Chris Bailey-Kellogg PhD
Associate Professor of Computer Science,
Dartmouth College
Thank you again for the wonderful support, we will see you at the next seminar.
For more information: Email Us Here
